Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC

NCT00201435 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

224

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasm

Interventions

DRUG: Paclitaxel weekly in combination with capecitabine
DRUG: Docetaxel every 3 week in combination with capecitabine

Sponsor

Norwegian Breast Cancer Group